
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.110 | 1.180 | 0.070 |
Shares | 98.890 | 98.890 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.297 | 17.158 |
Price to Book | 3.469 | 2.172 |
Price to Sales | 2.219 | 1.767 |
Price to Cash Flow | 12.295 | 11.541 |
Dividend Yield | 2.444 | 2.972 |
5 Years Earnings Growth | 6.191 | 7.025 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 48.470 | 10.267 |
Industrials | 31.480 | 40.463 |
Consumer Cyclical | 6.980 | 5.726 |
Technology | 4.880 | 8.127 |
Consumer Defensive | 4.260 | 4.632 |
Financial Services | 3.930 | 20.864 |
Number of long holdings: 27
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 46.04 | 11,782.0 | +0.38% | |
Volvo B | SE0000115446 | 6.19 | 297.10 | +2.87% | |
Sandvik AB | SE0000667891 | 4.97 | 242.20 | +2.32% | |
Hexagon B | SE0015961909 | 4.83 | 107.78 | +0.00% | |
Beijer Ref | SE0015949748 | 3.92 | 172.45 | +1.80% | |
Essity B | SE0009922164 | 3.86 | 252.10 | +0.80% | |
SEB A | SE0000148884 | 3.72 | 177.70 | -0.11% | |
Autoliv DRC | SE0021309614 | 3.26 | 1,148.00 | -1.61% | |
Epiroc A | SE0015658109 | 2.83 | 196.90 | +2.02% | |
SWECO B | SE0014960373 | 2.57 | 165.60 | +4.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 138.02B | -0.72 | 13.67 | 11.33 | ||
Handelsbanken Global Tema (A1 SEK) | 52.19B | -3.23 | 9.16 | 10.93 | ||
Handelsbanken Global Tema (B1 SEK) | 52.19B | -3.23 | 9.16 | 10.95 | ||
SE0010127894 | 40.91B | -5.04 | 4.85 | - | ||
Handelsbanken Multi Asset 50 A1 S | 31.51B | -0.21 | 5.67 | 4.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review